Abstract | BACKGROUND:
Vitamin K-dependent factors protect against vascular and renovascular calcification, and vitamin K antagonists may be associated with a decreased glomerular filtration rate (GFR). OBJECTIVES: This study analyzed changes in GFR during long-term treatment with warfarin or dabigatran etexilate (DE) in patients enrolled in the RE-LY (Randomized Evaluation of Long Term Anticoagulation Therapy) trial. METHODS: Of the 18,113 patients in the RE-LY study randomized to receive DE (110 mg or 150 mg twice daily) or warfarin, 16,490 patients with atrial fibrillation had creatinine values measured at baseline and at least 1 follow-up visit. Changes in GFR for up to 30 months were evaluated. RESULTS: GFR declined in all treatment groups. After an average of 30 months, the mean ± SE decline in GFR was significantly greater with warfarin (-3.68 ± 0.24 ml/min) compared with DE 110 mg (-2.57 ± 0.24 ml/min; p = 0.0009 vs. warfarin) and DE 150 mg (-2.46 ± 0.23 ml/min; p = 0.0002 vs. warfarin). A decrease in GFR >25% was less likely with DE 110 mg (hazard ratio: 0.81 [95% confidence interval: 0.69 to 0.96]; p = 0.017) or DE 150 mg (hazard ratio: 0.79 [95% confidence interval: 0.68 to 0.93]; p = 0.0056) than with warfarin in the observation period >18 months. Patients with poor international normalized ratio control (i.e., time in therapeutic range <65%) exhibited a faster decline in GFR. A more pronounced decline in GFR was associated with previous warfarin use and with the presence of diabetes. CONCLUSIONS:
|
Authors | Michael Böhm, Michael D Ezekowitz, Stuart J Connolly, John W Eikelboom, Stefan H Hohnloser, Paul A Reilly, Helmut Schumacher, Martina Brueckmann, Stephan H Schirmer, Mario T Kratz, Salim Yusuf, Hans-Christoph Diener, Ziad Hijazi, Lars Wallentin |
Journal | Journal of the American College of Cardiology
(J Am Coll Cardiol)
Vol. 65
Issue 23
Pg. 2481-93
(Jun 16 2015)
ISSN: 1558-3597 [Electronic] United States |
PMID | 26065986
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Anticoagulants
- Benzimidazoles
- Pyridines
- Warfarin
- Dabigatran
|
Topics |
- Aged
- Aged, 80 and over
- Anticoagulants
(pharmacology, therapeutic use)
- Atrial Fibrillation
(diagnosis, drug therapy, physiopathology)
- Benzimidazoles
(pharmacology, therapeutic use)
- Dabigatran
- Female
- Follow-Up Studies
- Glomerular Filtration Rate
(drug effects, physiology)
- Humans
- Kidney
(drug effects, physiology)
- Male
- Middle Aged
- Pyridines
(pharmacology, therapeutic use)
- Risk Factors
- Single-Blind Method
- Warfarin
(pharmacology, therapeutic use)
|